STOCK TITAN

Biofrontera Inc. (BFRI) CEO converts 62,500 RSUs into common shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Biofrontera Inc. CEO and Chairman Hermann Luebbert converted 62,500 restricted stock units (RSUs) into 62,500 shares of common stock on July 28, 2026. These RSUs are part of a 125,000-unit award granted on July 22, 2025, vesting in two equal yearly installments beginning July 22, 2026. After the conversion, he directly held 352,711 shares of common stock and 62,500 RSUs from this grant, with RSUs having different terms expressly excluded.

Positive

  • None.

Negative

  • None.
Insider Luebbert Hermann
Role CEO & Chairman
Type Security Shares Price Value
Exercise Restricted Stock Units F1, F2, F3 62,500 $0.00 $0.00
Exercise Common Stock F1 62,500 -- --
Holdings After Transaction: Restricted Stock Units — 62,500 shares (Direct); Common Stock — 352,711 shares (Direct)
Footnotes (3)
  1. F1. Each restricted stock unit represents a contingent right to receive one share of BFRI common stock, subject to the company's discretion to settle the restricted stock units, in whole or in part, in cash, as discussed below in footnote 2. The Company elected to convert the restricted stock units into common stock on a one-for-one basis.
  2. F2. On July 22, 2025, the Reporting Person was granted 125,000 restricted stock units, vesting in two equal yearly installments for the first two years following the grant date, beginning on July 22, 2026. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date.
  3. F3. Restricted stock units with different terms are not included.
RSUs Converted 62,500 units Restricted stock units converted into common stock on July 28, 2026
Shares Acquired 62,500 shares Common stock received upon RSU conversion on July 28, 2026
Post-transaction Common Shares 352,711 shares Direct common stock holdings of the CEO after the RSU conversion
Original RSU Grant 125,000 units RSUs granted on July 22, 2025, vesting over two years
Remaining RSUs from Grant 62,500 units Unconverted RSUs from the July 22, 2025 125,000-unit award
Settlement Window 60 days Period after vesting within which each RSU is settled in shares, cash or both
Restricted stock units financial
"Each restricted stock unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"represents a contingent right to receive one share of BFRI common stock"
vesting financial
"125,000 restricted stock units, vesting in two equal yearly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
settled financial
"Each vested restricted stock unit will be settled, at the Company's discretion"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Biofrontera (BFRI) report for its CEO?

Hermann Luebbert converted 62,500 restricted stock units into 62,500 shares of common stock on July 28, 2026, increasing his directly held common shares as part of an existing equity award.

How many Biofrontera (BFRI) shares does the CEO hold after this Form 4?

Following the RSU conversion, CEO Hermann Luebbert directly holds 352,711 shares of Biofrontera common stock, according to the reported post-transaction holdings in the Form 4 data.

What are the terms of the 125,000 RSU grant reported by Biofrontera (BFRI)?

The CEO received 125,000 RSUs on July 22, 2025, vesting in two equal yearly installments starting July 22, 2026. Each vested RSU is settled in shares, cash, or a combination within 60 days at the company’s discretion.

How many Biofrontera (BFRI) RSUs from this grant remain after the transaction?

After converting 62,500 RSUs into common stock, 62,500 RSUs from this specific 125,000-unit grant remain reported. The notes specify that RSUs with different terms are not included in this figure.

Were the Biofrontera (BFRI) CEO’s transactions under a Rule 10b5-1 plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not marked, meaning these transactions are not affirmed as made under a Rule 10b5-1 trading plan in this report.

What type of securities were converted in Biofrontera (BFRI)’s Form 4?

The CEO converted Restricted Stock Units into common stock. Each RSU represents a contingent right to receive one share of Biofrontera common stock, and the company elected one-for-one share settlement.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Luebbert Hermann

(Last)(First)(Middle)
660 MAIN STREET
FIRST FLOOR

(Street)
WOBURN MASSACHUSETTS 01801

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Biofrontera Inc. [ BFRI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
CEO & Chairman
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/28/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/28/2026M62,500A(1)352,711D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)07/28/2026M62,500 (2) (2)Common Stock62,500$062,500(3)D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of BFRI common stock, subject to the company's discretion to settle the restricted stock units, in whole or in part, in cash, as discussed below in footnote 2. The Company elected to convert the restricted stock units into common stock on a one-for-one basis.
2. On July 22, 2025, the Reporting Person was granted 125,000 restricted stock units, vesting in two equal yearly installments for the first two years following the grant date, beginning on July 22, 2026. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date.
3. Restricted stock units with different terms are not included.
/s/ Daniel Hakansson, Attorney-in-fact for Hermann Luebbert07/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)